je.st
news
Tag: trial
Galena Biopharma Enrolls 700th Patient in NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
2015-02-09 18:35:24| Biotech - Topix.net
Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced enrollment of the 700th patient in the NeuVax Phase 3 PRESENT clinical trial. NeuVax is a first-in-class, HER2-directed cancer immunotherapy under evaluation to prevent breast cancer recurrence after standard of care treatment in the adjuvant setting.
Tags: present
trial
phase
patient
Alkermes says trial results of reformulated Tecfidera show fewer side effects
2015-02-09 15:30:42| Biotech - Topix.net
Irish drug company Alkermes says results of an early-stage trial of its reformulated version of Biogen Idec's blockbuster multiple sclerosis pill show it may have fewer side effects, and has potential to be taken once a day instead of twice. Alkermes , which has a significant research facility in Waltham, said the Phase 1 trial of 104 healthy people compared its reformulation of the active ingredient in Tecfidera, which it calls ALKS 8700, to both the original and a placebo.
Tags: show
results
side
effects
Their Opinion: War crimes in U.S. name must go to trial
2015-02-09 02:21:58| IT Services - Topix.net
What happened at the Abu Ghraib prison during the early days of the Iraq war is no secret: The world saw the appalling photos. Detainees under American control were raped, beaten, shocked, stripped, starved of food and sleep, hung by their wrists, threatened with death and, in at least one case, murdered.
Envivio powers Chunghwa Telecom 4K HEVC trial
2015-02-05 16:00:38| Digital TV News
Envivio (NASDAQ: ENVI) has announced that Chunghwa Telecom has selected Envivio video solutions for its 4K HEVC streaming service trial. In the trial, Envivio is using its Muse Ultra HD software to support two modes of 4K HEVC delivery to a wide range of devices for Chunghwa.
Tags: trial
powers
telecom
chunghwa
OPKO Submits Investigational New Drug Application To Initiate A Phase 2a Trial For Its Long-Acting Coagulation Factor VIIa-CTP To Treat Hemophilia
2015-02-04 06:38:34| drugdiscoveryonline Home Page
OPKO Health, Inc. announced the submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) to conduct a Phase 2a study of OPKO's long-acting version of coagulation Factor VIIa (Factor VIIa-CTP) for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX
Tags: to
application
trial
factor
Sites : [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] next »